These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3213262)

  • 21. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease.
    Bonner GF; Walczak M; Kitchen L; Bayona M
    Am J Gastroenterol; 2000 Aug; 95(8):1946-8. PubMed ID: 10950040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of solasodin in the treatment of some internal diseases].
    Milimovka ME; Konovalov MN; Boĭdykh RI; Kazakov MG; Rybnikov NI; Strizhevskaia AZ
    Vrach Delo; 1966 May; 5():62-5. PubMed ID: 5995513
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
    Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
    Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Trans-synovial kinetics of tiaprofenic acid].
    Kurowski M
    Z Rheumatol; 1988; 47(3):173-6. PubMed ID: 3213265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of zinc supplementation on the phagocytic functions of polymorphonuclears in patients with inflammatory rheumatic diseases.
    Peretz A; Cantinieaux B; Nève J; Siderova V; Fondu P
    J Trace Elem Electrolytes Health Dis; 1994 Dec; 8(3-4):189-94. PubMed ID: 7599511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of Eumotol in the treatment of rheumatic diseases].
    Zimmermann-Górska I; Konieczna B
    Reumatologia; 1973; 11(3):305-8. PubMed ID: 4748105
    [No Abstract]   [Full Text] [Related]  

  • 28. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
    Spanakis E; Sidiropoulos P; Papadakis J; Ganotakis E; Katsikas G; Karvounaris S; Bizaki A; Kritikos H; Boumpas DT
    J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal muscle wastage in Crohn's disease: a pathway shared with heart failure?
    Cuoco L; Vescovo G; Castaman R; Ravara B; Cammarota G; Angelini A; Salvagnini M; Dalla Libera L
    Int J Cardiol; 2008 Jul; 127(2):219-27. PubMed ID: 17692969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Erosive enteropathy in a patient with polyarthritis].
    Bogas M; Afonso Mdo C; Araújo D
    Acta Reumatol Port; 2006; 31(4):349-54. PubMed ID: 17334047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Gyselbrecht L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2279-84. PubMed ID: 8835562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
    D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
    Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs].
    Stock KP; Bach GL
    Z Rheumatol; 1988; 47(3):177-81. PubMed ID: 3213266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients].
    Simon B; Leucht U; Amon I; Brandau J; Müller P
    Z Gastroenterol; 1993 Jun; 31(6):395-400. PubMed ID: 8212757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotoxin in the plasma of patients with inflammatory rheumatic diseases.
    Wagener P; Busch J; Hammer M; Brunkhorst R
    Scand J Rheumatol; 1988; 17(4):301-3. PubMed ID: 3263700
    [No Abstract]   [Full Text] [Related]  

  • 37. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
    Mielants H; Veys EM; De Vos M; Cuvelier C; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2266-72. PubMed ID: 8835560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothalamic-pituitary-adrenal axis function in ankylosing spondylitis.
    Imrich R; Rovensky J; Zlnay M; Radikova Z; Macho L; Vigas M; Koska J
    Ann Rheum Dis; 2004 Jun; 63(6):671-4. PubMed ID: 15140773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.
    Akkoc N; van der Linden S; Khan MA
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):539-57. PubMed ID: 16777581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Suspected cases of severe side effects after infliximab (Remicade) in Germany].
    Andus T; Stange EF; Höffler D; Keller-Stanislawski B
    Med Klin (Munich); 2003 Aug; 98(8):429-36. PubMed ID: 12928808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.